Product
ORG101
Aliases
ORG101 - Experimental 1
1 clinical trial
2 indications
Indication
Acne VulgarisIndication
AcneClinical trial
A Phase I, Multi-center, Double-blind, Randomized, Dose Escalating, Parallel Group, Placebo-controlled Safety, Tolerability and Immunogenicity Study of ORI-A-ce001 for the Treatment of Facial Acne VulgarisStatus: Completed, Estimated PCD: 2023-11-27